The use of HLA class I tetramers to design a vaccination strategy for melanoma patients

This publication has 38 references indexed in Scilit:

• Tracking T cells with tetramers: new tales from new tools
  Nature Reviews Immunology, 2002
• Progress in human tumour immunology and immunotherapy
  Nature, 2001
• Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
  The Journal of Experimental Medicine, 2000
• Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach
  European Journal of Immunology, 2000
• Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3
  The Journal of Experimental Medicine, 1999
• Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
  Proceedings of the National Academy of Sciences, 1998
• Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
  Current Biology, 1998
• Cancer Tumor antigens
  Current Opinion in Immunology, 1997
• Human neoplasms elicit multiple specific immune responses in the autologous host.
  Proceedings of the National Academy of Sciences, 1995
• A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
  European Journal of Immunology, 1994